Modeling the response to interleukin-21 to inform natural killer cell immunotherapy.
Ontology highlight
ABSTRACT: Natural killer (NK) cells are emerging agents for cancer therapy. Several different cytokines are used to generate NK cells for adoptive immunotherapy including interleukin (IL)-2, IL-12, IL-15 and IL-18 in solution, and membrane-bound IL-21. These cytokines drive NK cell activation through the integration of signal transducers and activators of transcription (STAT) and nuclear factor-kappa B (NF-κB) pathways, which overlap and synergize, making it challenging to predict optimal cytokine combinations for both proliferation and cytotoxicity. We integrated functional assays for NK cells cultured in a variety of cytokine combinations with mathematical modeling using feature selection and mechanistic regression models. Our regression model successfully predicts NK cell proliferation for differ
SUBMITTER: Nayak I
PROVIDER: S-EPMC11792776 | biostudies-literature | 2025 Feb
REPOSITORIES: biostudies-literature
ACCESS DATA